World Journal of Surgery

, Volume 41, Issue 4, pp 1012–1018 | Cite as

Impact of Safe Distance on Long-Term Outcome After Surgical Therapy of Alveolar Echinococcosis

  • Andreas Hillenbrand
  • Beate Gruener
  • Wolfgang Kratzer
  • Peter Kern
  • Tilmann Graeter
  • Thomas F. Barth
  • Klaus Buttenschoen
  • Doris Henne-Bruns
Original Scientific Report

Abstract

Introduction

In humans, alveolar echinococcosis (AE) is a serious helminthic disease. Additionally to a long-term medical treatment, in all suitable cases a complete surgical resection with a 20-mm safe distance (minimal distance of larval tissue to resection margin) is recommended. We analyzed the influence of the safe distance and the effect of the postoperative anthelmintic prophylaxis on the long-term outcome of patients who underwent surgery with curative intent.

Objective

Ninety-two operated patients were evaluated regarding the safe distance, the duration of medical therapy with benzimidazole derivates, and the further course of AE.

Results

Median follow-up after surgical procedure was 8.3 years. Twelve patients had a safe distance of 20 mm or more, 16 patients between 10 and 19 mm, 21 patients between 1 and 10 mm, and 10 patients 1 mm. In a further 33 patients, the affected liver was resected without any safe distance. Recurrence of AE was seen in 15 patients between 4 months and 24 years after initial operation. Safe distances of patients with recurrent disease were: 13 ×  no safe distance, one patient with 1-mm and one patient with 13-mm safe distance. In all patients except one with recurrent AE, postoperative therapy with benzimidazole derivates was stopped.

Conclusion

A safe distance of at least 1 mm in combination with medical anthelmintic treatment continuing for two years might offer a good chance of being disease-free long term, but the exact period of medical treatment needed is not defined. The therapy regime should be determined through an interdisciplinary approach in specialized centers.

Keywords

Liver Resection Safe Distance Alveolar Echinococcosis Benzimidazole Derivate Final Host 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors gratefully acknowledge the important contributions and guidance provided by the following members of EmUG (Echinococcus multilocularis Ulm Group): S. Öztürk, K. Mouratidou.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest in the research.

References

  1. 1.
    Eckert J, Deplazes P (2004) Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 17(1):107–135CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Eckert J, Deplazes P (1999) Alveolar echinococcosis in humans: the current situation in Central Europe and the need for countermeasures. Parasitol Today 15(8):315–319CrossRefPubMedGoogle Scholar
  3. 3.
    Kern P, Bardonnet K, Renner E et al (2003) European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis 9(3):343–349CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ammann RW, Eckert J (1996) Cestodes: echinococcus. Gastroenterol Clin North Am 25:655–689CrossRefPubMedGoogle Scholar
  5. 5.
    Schweiger A, Ammann RW, Candinas D et al (2007) Human alveolar echinococcosis after fox population increase, Switzerland. Emerg Infect Dis 13(6):878–882CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Romig T (2009) Echinococcus multilocularis in Europe: state of the art. Vet Res Commun 33(Suppl 1):31–34CrossRefPubMedGoogle Scholar
  7. 7.
    Schneider R, Aspöck H (2011) Auer H (2013) Unexpected increase of alveolar echincoccosis, Austria. Emerg Infect Dis 19(3):475–477CrossRefGoogle Scholar
  8. 8.
    Brunetti E, Kern P, Vuitton DA (2010) Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 114(1):1–16CrossRefPubMedGoogle Scholar
  9. 9.
    Buttenschoen K, Gruener B, Carli Buttenschoen D et al (2009) Palliative operation for the treatment of alveolar echinococcosis. Langenbecks Arch Surg 394:199–204CrossRefPubMedGoogle Scholar
  10. 10.
    Torgerson PR, Schweiger A, Deplazes P et al (2008) Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 49(1):72–77CrossRefPubMedGoogle Scholar
  11. 11.
    Eckert J, Thompson RC, Mehlhorn H (1983) Proliferation and metastases formation of larval echinococcus multilocularis. I. Animal model, macroscopical and histological findings. Z Parasitenkd 69(6):737–748CrossRefPubMedGoogle Scholar
  12. 12.
    Kawamura N, Kamiyama T, Sato N et al (2011) Long-term results of hepatectomy for patients with alveolar echinococcosis: a single-center experience. J Am Coll Surg 212:804–812CrossRefPubMedGoogle Scholar
  13. 13.
    Kern P, Wen H, Sato N et al (2006) WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 55(Suppl):S283–S287CrossRefPubMedGoogle Scholar
  14. 14.
    Kern P (2010) Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 23(5):505–512CrossRefPubMedGoogle Scholar
  15. 15.
    Kern P, Bardonnet K, Renner E et al (2003) European echinococcosis registry. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis 9(3):343–349CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Carli Buttenschoen K, Buttenschoen D, Gruener B et al (2009) Long-term experience on surgical treatment of alveolar echinococcosis. Langenbecks Arch Surg 394:689–698CrossRefGoogle Scholar
  17. 17.
    Kadry Z, Renner EC, Bachmann LM et al (2005) Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis. Br J Surg 92(9):1110–1116CrossRefPubMedGoogle Scholar
  18. 18.
    Ayifuhan A, Tuerganaili A, Jun C et al (2012) Surgical treatment for hepatic alveolar echinococcosis: report of 50 cases. Hepatogastroenterology 59(115):790–793PubMedGoogle Scholar
  19. 19.
    Bresson-Hadni S, Vuitton DA, Bartholomot B et al (2000) A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol 12(3):327–336CrossRefPubMedGoogle Scholar
  20. 20.
    Charbonnet P, Bühler L, Sagnak E et al (2004) Long-term followup of patients with alveolar echinococcosis. Ann Chir 129(6–7):337–342CrossRefPubMedGoogle Scholar
  21. 21.
    Buttenschoen K, Schorcht P, Reuter S et al (2001) Surgical therapy of alveolar echinococcosis and long-term outcome. Chirurg 72(5):566–572CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2016

Authors and Affiliations

  • Andreas Hillenbrand
    • 1
  • Beate Gruener
    • 2
  • Wolfgang Kratzer
    • 2
  • Peter Kern
    • 2
  • Tilmann Graeter
    • 3
  • Thomas F. Barth
    • 4
  • Klaus Buttenschoen
    • 5
  • Doris Henne-Bruns
    • 1
  1. 1.Department of General and Visceral SurgeryUniversity Hospital UlmUlmGermany
  2. 2.Department of Internal MedicineUniversity Hospital UlmUlmGermany
  3. 3.Department of Diagnostic and Interventional RadiologyUniversity Hospital UlmUlmGermany
  4. 4.Department of PathologyUniversity Hospital UlmUlmGermany
  5. 5.Division of General Surgery, Department of SurgeryUniversity of AlbertaEdmontonCanada

Personalised recommendations